Bio-Rad Labs (BIO) Tops Q1 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Bio-Rad Labs (BIO) PT Lifted to $165 at Jefferies
May 6, 2015 8:09 AM EDTJefferies analyst Brandon Couillard reiterated a Buy rating and lifted his price target on Bio-Rad Labs (NYSE: BIO) to $165.00 (from $150.00) following much better-than-expected Q1 results.
Couillard commented, "BIO's 1Q15 EPS of $0.61 dusted our view ($0.36) on vastly better profitability, despite a sizable... More



